Voriconazole Use for Endemic Fungal Infections-Reference-Cited by-同舟云学术

Voriconazole Use for Endemic Fungal Infections

Published:2009-04 Issue:4 Volume:53 Page:1648-1651
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Freifeld Alison¹,Proia Laurie²,Andes David³,Baddour Larry M.⁴,Blair Janis⁵,Spellberg Brad⁶,Arnold Sandra⁷,Lentnek Arnold⁸,Wheat L. Joseph⁹

Affiliation:

1. University of Nebraska Medical Center, Omaha, Nebraska

2. Rush Medical College, Chicago, Illinois

3. University of Wisconsin, Madison, Wisconsin

4. Mayo Clinic, Rochester, Minnesota

5. Mayo Clinic, Phoenix, Arizona

6. Harbor—UCLA, Los Angeles, California

7. University of Tennessee, Memphis, Tennessee

8. Wellstar Clinical Trials, Marietta, Georgia

9. Miravista Labs, Indianapolis, Indiana

Abstract

ABSTRACT In a retrospective review of 24 patients with histoplasmosis, blastomycosis, or coccidioidomycosis treated with voriconazole (most for salvage therapy), the outcome was favorable (improved or stable) for 22 (95.8%) within 2 months of starting voriconazole and for 20 (83.3%) at the last follow-up. Prospective studies are required to determine its role in the treatment of endemic mycoses.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01148-07

Reference27 articles.

1. Al-Agha, O. M., M. Mooty, and A. Salarieh. 2006. A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin. Arch. Pathol. Lab. Med.130:120-123.

2. Antony, S. J., P. Jurczyk, and L. Brumble. 2006. Successful use of combination antifungal therapy in the treatment of coccidioides meningitis. J. Natl. Med. Assoc.98:940-942.

3. Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

4. Bakleh, M., A. J. Aksamit, I. M. Tleyjeh, and W. F. Marshall. 2005. Successful treatment of cerebral blastomycosis with voriconazole. Clin. Infect. Dis.40:e69-e71.

5. Borgia, S. M., J. D. Fuller, A. Sarabia, and P. El-Helou. 2006. Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen. Med. Mycol.44:659-664.

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endemic mycoses – are we making progress in management?;Current Opinion in Infectious Diseases;2023-09-26

2. Headaches in a Horseback Rider;Open Forum Infectious Diseases;2023-03-01

3. A difficult-to-treat pleuropulmonary histoplasmosis in a patient with rheumatoid arthritis in Taiwan;Journal of Microbiology, Immunology and Infection;2023-02

4. Blastomycosis: A Review of Mycological and Clinical Aspects;Journal of Fungi;2023-01-14

5. Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections;Pharmaceutics;2023-01-12